Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 39 (ANKRD39)

Target
ANKRD39
Molecular classification
Other (member of the ankyrin repeat domain-containing protein family), Ankyrin repeat protein, Scaffold protein (potential adaptor or regulatory component by domain context)
01

Overview

ANKRD39, or ankyrin repeat domain-containing protein 39, is a member of the ankyrin repeat domain protein family, characterized by repeating structural motifs that typically mediate protein-protein interactions[1][2]. Its gene is expressed in many tissues, but its function is largely inferred based on domain architecture and broad interaction networks rather than defined enzymatic activity or receptor function[1][5][6]. Recent transcriptomic studies in Alzheimer’s disease suggest ANKRD39 may operate as a hub gene influencing autophagy and intracellular signaling, but mechanistic details remain unclear[1]. While ankyrin repeat domains generally serve as scaffolds or adaptors in numerous cellular processes, ANKRD39 itself is not directly implicated as a receptor, enzyme, transporter, nor does it have established roles in other well-characterized molecular families[2]. Current research highlights its context-specific associations rather than direct therapeutic actions, and further experimental work is needed to define its functional role and any disease contribution[1][2][6].

Other names
Ankyrin repeat domain 39HSPC200MGC41816ANR39_HUMAN (UniProt mnemonic)Ankyrin repeat domain-containing protein 39
02

Biological functions

Protein-protein interaction scaffold (by ankyrin repeat domain)Regulation of intracellular signaling pathways (inferred from network associations)Possible role in autophagy processes (from disease studies)Potential modulation of gene expression (affected by transcription factor perturbations)Other (wide variety of protein interactions typical of ankyrin repeat family, but specific functions unknown)
03

Disease associations

Alzheimer’s disease (AD): Emerging candidate hub gene in transcriptomic landscapes associated with autophagy and signaling changes in AD brain tissueOther: No clear or direct link to other diseases; not prominent in acute myeloid leukemia, diabetes, stem cell, or cancer studies reviewed to date

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 39 (ANKRD39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 39 (ANKRD39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call